We are live on ! Find out more
CC

Clearline Capital Portfolio holdings

AUM $1.93B
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
+20.57%
1 Year Est. Return
+38.13%
3 Year Est. Return
+17.96%
5 Year Est. Return
-8.68%
10 Year Est. Return
-18.93%
AUM
$2.68B
AUM Growth
+$1.01B
Cap. Flow
+$730M
Cap. Flow %
27.27%
Top 10 Hldgs %
69.8%
Holding
147
New
31
Increased
27
Reduced
30
Closed
38

Top Buys

Rank Stock Value
1
GTLS
Chart Industries
GTLS
+$43.5M
2
FLS icon
Flowserve
FLS
+$33.2M
3
VOYG
Voyager Technologies
VOYG
+$23.2M
4
BDX icon
Becton Dickinson
BDX
+$16.4M
5
ACHC icon
Acadia Healthcare
ACHC
+$13.5M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$29.1M
2
CORZ icon
Core Scientific
CORZ
+$19.7M
3
MDB icon
MongoDB
MDB
+$17.6M
4
ADBE icon
Adobe
ADBE
+$15.3M
5
FLR icon
Fluor
FLR
+$15.3M

Sector Composition

Rank Sector Weight
1 Technology 17.35%
2 Industrials 8.59%
3 Healthcare 4.88%
4 Communication Services 3.17%
5 Financials 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITOS
101
DELISTED
iTeos Therapeutics
ITOS
$548K 0.02%
+55,013
New +$443K
IART icon
102
Integra LifeSciences
IART
$1.52B
$525K 0.02%
42,814
– –
NCNO icon
103
nCino
NCNO
$1.93B
$503K 0.02%
18,000
– –
JACK icon
104
Jack in the Box
JACK
$299M
$494K 0.02%
28,304
+18,000
+175% +$405K
SNDX icon
105
Syndax Pharmaceuticals
SNDX
$1.82B
$320K 0.01%
34,177
– –
HUM icon
106
Humana
HUM
$45.8B
$293K 0.01%
1,200
-1,043
-47% -$260K
MRVI icon
107
Maravai LifeSciences
MRVI
$987M
$285K 0.01%
118,242
-87,097
-42% -$183K
CYTK icon
108
Cytokinetics
CYTK
$10.9B
$225K 0.01%
6,817
-159,660
-96% -$5.55M
FUN icon
109
Cedar Fair
FUN
$1.8B
$204K 0.01%
+6,704
New +$225K
ADPT icon
110
Adaptive Biotechnologies
ADPT
$3.61B
– –
-586,380
Closed -$4.36M
AOSL icon
111
Alpha and Omega Semiconductor
AOSL
$922M
– –
-372,780
Closed -$9.27M
CMRC
112
Commerce.com Inc Series 1
CMRC
$234M
– –
-1,064,741
Closed -$6.13M
BSY icon
113
Bentley Systems
BSY
$10.2B
– –
-119,637
Closed -$4.71M
BUR icon
114
Burford Capital
BUR
$922M
– –
-36,054
Closed -$476K
CEG icon
115
Constellation Energy
CEG
$96.4B
– –
-30,696
Closed -$6.19M
CPRT icon
116
Copart
CPRT
$27.6B
– –
-12,987
Closed -$735K
CRDO icon
117
Credo Technology Group
CRDO
$38.8B
– –
-18,000
Closed -$723K
DHR icon
118
Danaher
DHR
$138B
– –
-7,386
Closed -$1.51M
DIN icon
119
Dine Brands
DIN
$448M
– –
-19,956
Closed -$464K
DNUT icon
120
Krispy Kreme
DNUT
$562M
– –
-703,138
Closed -$3.46M
ESTC icon
121
Elastic
ESTC
$6.37B
– –
-12,894
Closed -$1.15M
HELE icon
122
Helen of Troy
HELE
$658M
– –
-82,770
Closed -$4.43M
HON icon
123
Honeywell
HON
$77.9B
– –
-13,827
Closed -$2.76M
IBIT icon
124
iShares Bitcoin Trust
IBIT
$48.2B
– –
-60,566
Closed -$2.84M
INFA
125
DELISTED
Informatica
INFA
– –
-184,944
Closed -$3.23M
2 3 4
5
6

Similar funds

DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
HC
Hamilton Capital Columbus, Ohio $1.93B AUM
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $1.93B AUM 21.66% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return

Clearline Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Clearline Capital held 147 positions worth $2.68B, up 61% from $1.66B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Clearline Capital deployed $730M of net new capital in Q2 2025, opening 31 new positions and adding to 27 existing holdings. Its largest new stake was Flowserve: 705,266 shares worth $36.9M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 29% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Core Scientific, an estimated $19.7M trimmed.

  • Clearline Capital's largest Q2 2025 buy was Flowserve: 705,266 shares worth $36.9M.
  • Clearline Capital added most to Chart Industries in Q2 2025, an estimated $43.5M increase.
  • Clearline Capital's biggest Q2 2025 reduction was Core Scientific, cutting an estimated $19.7M.
  • Clearline Capital fully exited NVIDIA in Q2 2025, selling an estimated $29.1M.
  • Clearline Capital's ten largest holdings make up 70% of its $2.68B portfolio in Q2 2025.
  • Clearline Capital opened 31 new positions and closed 38 in Q2 2025.
  • Clearline Capital's portfolio value rose 61% quarter-over-quarter to $2.68B.

Based on Clearline Capital's 13F filing for Q2 2025, filed 14 Aug 2025.